This table presents recent patent oppositions filed by Elkington And Fife Llp against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISK A/SNov 7, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 13, 2024
EP2835059High Protein Liquid Enteral Nutritional CompositionN.V. NUTRICIASep 5, 2024
EP3744326Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS, INC.Sep 4, 2024
EP3607936Pharmaceutical CompositionMEXICHEM FLUOR S.A. DE C.V.Aug 8, 2024
EP3610871Pharmaceutical CompositionMEXICHEM FLUOR S.A. DE C.V.Aug 8, 2024
EP3897647Combinations Of A Hdm2-P53 Interaction Inhibitor And A Bcl2 Inhibitor And Their Use For Treating CancerNOVARTIS AGAug 1, 2024
EP3500241Combination Therapy For CopdCHIESI FARMACEUTICI S.P.A.Jul 4, 2024
EP4106757Methods Involving Neutrophil Elastase Inhibitor Alvelestat For Treating Respiratory Disease Mediated By Alpha-1 Antitrypsin DeficiencyMEREO BIOPHARMA 4 LIMITEDMay 23, 2024
EP3340989Mdm2 Inhibitors And Combinations ThereofNOVARTIS AGMay 15, 2024